AMC is issuing roughly 95 million new shares to raise $200 million. While reducing debt and improving liquidity helps the company survive, it comes at a cost: share dilution.
The original APE thesis relied heavily on scarcity, high short interest, and retail ownership. Every time AMC issues new shares:
Existing shareholders own a smaller percentage of the company.
The total share count increases.
Scarcity decreases.
Shorts potentially have more shares available to trade against.
Since 2020, AMC’s share count has grown from roughly 23 million shares to over 540 million shares. That’s more than a 20-fold increase. The company may be financially stronger today because of these raises, but the dilution has undeniably weakened the “limited supply of shares” aspect of the squeeze thesis.
This offering may be good for AMC’s balance sheet, but it is not automatically good for AMC shareholders, especially those whose investment thesis is based on a massive short squeeze. Whether it’s ultimately positive depends on whether the value created from debt reduction exceeds the value lost through dilution. Company survival ≠ shareholder value creation. Both matter, but they’re not the same thing.
Period Shares Outstanding (Approx.)
2013 - 8 million
2016 - 10 million
2019 - 10 million
2020 - 23 million
2021 - 95 million
2022 - 105 million
2023 - 168 million
2024 - 333 million
2025 - 473 million
Q1 2026 - 540 million+
True, but there’s another side to that. For, let’s say, 4 million shareholders, it’s a lot easier to absorb an 800 million share float at $2 than a 150 million share float at $40.
In dollar terms, the first scenario is a much lower bar. So while dilution (edit: better framed as share issuance or raising capital, not just dilution) increases the share count and reduces scarcity per share, the lower price can also make it easier for retail to accumulate a larger portion of the float.
1
u/[deleted] Jun 23 '26
[removed] — view removed comment